Becaplermin gel in the treatment of diabetic neuropathic foot ulcers

References

• AlbertSCost-effective management of recalcitrant diabetic foot ulcersClin Podiatr Med Surg2002194839112471856
   PubMedGoogle Scholar
• BakkerKFosterAVMvan HoutoumWHTime to act2005The NetherlandsInternational Diabetes Federation and International Working Group of the Diabetic Foot
   Google Scholar
• BennettSPGriffithsGDSchorAMGrowth factors in the treatment of diabetic foot ulcersBr J Surg2003901334612555288
   PubMed Web of Science ®Google Scholar
• BlackEVibe-PedersenJJorgensenLNDecrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic controlArch Surg2003138344012511146
   PubMedGoogle Scholar
• BlakytnyRJudeEThe molecular biology of chronic wounds and delayed healing in diabetesDiabet Med20062359460816759300
   PubMed Web of Science ®Google Scholar
• BoultonAJMThe diabetic foot: from art to science. The 18th Camillo Golgi lectureDiabetologia20044713435315309286
   PubMed Web of Science ®Google Scholar
• BoultonAJMKirsnerRSVileikyteLNeuropathic diabetic foot ulcersN Engl J Med2004351485515229307
   PubMed Web of Science ®Google Scholar
• BoultonAJMVileikyteLRagnarson-TennvallGThe global burden of diabetic foot diseaseLancet200536617192416291066
   PubMed Web of Science ®Google Scholar
• BreitbartASLaserJParrettBAccelerated diabetic wound healing using cultured dermal fibroblasts retrovirally transduced with the platelet-derived growth factor B geneAnn Plast Surg2003514091414520070
   PubMed Web of Science ®Google Scholar
• BrownRLBreedenMPGreenhalghDGPDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouseJ Surg Res199456562708015312
   PubMed Web of Science ®Google Scholar
• CastronuovoJJGhobrialIGiustiAMEffects of chronic wound fluid on the structure and biological activity of becaplermin (rhPDGF-BB) and becaplermin gelAm J Surg1998176Suppl 2A61S67S9777974
   PubMed Web of Science ®Google Scholar
• CavanaghPRLipskyBABradburyAWTreatment for diabetic foot ulcersLancet200536617253516291067
   PubMed Web of Science ®Google Scholar
• ColiaguriSBorch-JohnsenKGlümerCThere really is an epidemic of type 2 diabetesDiabetologia20054814596316007413
   PubMed Web of Science ®Google Scholar
• CrucianiMLipskyBAMengoliCAre granulocyte colony-stimulating factots beneficial in treating diabetic foot infections?Diabetes Care2005284546015677817
   PubMed Web of Science ®Google Scholar
• D’HemercourtPASmiellJMKarimMREffect of sodium carbomethylcellulose aqueous-based gel vs. becaplermin gel in patients with non-healing lower extremity diabetic ulcersWounds1998106975
   Web of Science ®Google Scholar
• EdmondsMEBlundellMPMorrisMEImproved survival of the diabetic foot: the role of a specialized foot clinicQ J Med198660763713774959
   PubMedGoogle Scholar
• EdmondsMThe diabetic foot, 2003Diabetes Metab Res Rev200420Suppl 1S9S1215150806
   PubMed Web of Science ®Google Scholar
• EdmondsMEFosterAVMSandersLJEdmondsMEFosterAVMSandersLJStage 3: the ulcerated footA Practical Manual of diabetic footcare2004aOxfordBlackwell62101
   Google Scholar
• EdmondsMEFosterAVMSandersLJEdmondsMEFosterAVMSandersLJStage 4: the infected footA Practical Manual of diabetic footcare2004bOxfordBlackwell10240
   Google Scholar
• EmbilJMPappKSibbladGRecombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of safetyWound Rep Reg200081628
   PubMed Web of Science ®Google Scholar
• EmingSAWhitsittJSHeLParticle-mediated gene transfer of PDGF isoforms promotes wound repairJ Invest Dermatol199911229730210084305
   PubMed Web of Science ®Google Scholar
• FalangaVWound healing and its impairment in the diabetic footLancet200536617364316291068
   PubMed Web of Science ®Google Scholar
• GhatnekarOPerssonUWillisMCost effectiveness of becaplermin in the treatment of diabetic foot ulcers in four European countriesPharmacoeconomist20011976778
   PubMed Web of Science ®Google Scholar
• HolsteinPESorensenSLimb salvage experience in a multidisciplinary diabetic foot unitDiabetes Care199922Suppl 2B9710310097908
   PubMed Web of Science ®Google Scholar
• HolsteinPEllitsgaardNOlsenBBDecreasing incidence of major amputations in people with diabetesDiabetologia200043844710952455
   PubMed Web of Science ®Google Scholar
• HolsteinPEllitsgaardNBornefeld OlsenBDecreasing incidence of major amputations in people with diabetesVASA2001582831
   Web of Science ®Google Scholar
• International Working Group on the Diabetic FootInternational consensus on the diabetic foot and practical guidelines on the management and prevention of the diabetic foot2007Brussels, BelguimInternational Working Group on the Diabetic Foot
   Google Scholar
• JeffcoateWPricePHardingKGWound healing and treatments for people with diabetic foot ulcersDiabetes Metab Res Rev200420Suppl 1S78S8915150819
   PubMed Web of Science ®Google Scholar
• JudeEBBlakytnyRBulmerJTransforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcersDiabet Med200219440712060054
   PubMed Web of Science ®Google Scholar
• KantorJMargolisDJTreatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysisDermatol Surg2001273475111298704
   PubMed Web of Science ®Google Scholar
• KirsnerRSBogensbergerGKlothLCMcCullochJMThe normal process of healingWound healing alternatives in management2002PhiladelphiaFA Davis334
   Google Scholar
• KövekerGBGrowth factors in clinical practiceInt J Clin Pract200054590311220987
   PubMed Web of Science ®Google Scholar
• LiechtyKWNesbitMHerlynMAdenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischaemic impaired wound healingJ Invest Dermatol19991133758310469337
   PubMed Web of Science ®Google Scholar
• ManLXParkJCTerryMJLentiviral gene therapy with platelet-derived growth factor B sustains acclerated healing of diabetic wounds over timeAnn Plast Surg20055581615985796
   PubMed Web of Science ®Google Scholar
• ManesCPapazoglouNSossidouEPrevalence of diabetic neuropathy and foot ulceration: identification of potential risk factors – a population-based studyWounds2002141115
   Web of Science ®Google Scholar
• MargolisDJCrombleholmeTHerlynMClinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcerWound Rep Reg2000a848093
   PubMed Web of Science ®Google Scholar
• MargolisDJKantorJSantannaJRisk factors for delayed healing of neuropathic diabetic foot ulcersArch Dermatol2000b1361531511115166
   PubMedGoogle Scholar
• MargolisDJAllen-TaylorLHoffstadOHealing diabetic neuropathic foot ulcers: are we getting better?Diabet Med2005a22172615660734
   PubMed Web of Science ®Google Scholar
• MargolisDJBartusCHoffstadOEffectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcersWound Rep Reg2005b135316
   PubMed Web of Science ®Google Scholar
• NagaiMKEmbilJMBecaplermin: recombinant platelet-derived growth factor, a new treatment for healing diabetic foot ulcersExpert Opin Biol2002221118
   PubMed Web of Science ®Google Scholar
• PapanasNMaltezosEEdmondsAThe Ten Commandments of the diabetic footBMJ20053311497
   Google Scholar
• PapanasNMaltezosEEdmondsMSt. Vincent declaration after 15 years or who cleft the devil’s foot?VASA2006a353416535960
   PubMed Web of Science ®Google Scholar
• PapanasNMaltezosEEdmondsMThe diabetic foot: a plea for the elementary?Acta Diabetol2006b43152317211568
   PubMed Web of Science ®Google Scholar
• PapanasNMaltezosEGrowth factors in the treatment of diabetic foot ulcers: new technologies, any promises?Int J Low Extrem Wounds20076375317344201
   PubMedGoogle Scholar
• ParkhouseNLe QuesnePMImpaired neurogenic vascular response in patients with diabetes and neuropathic foot lesionsN Engl J Med1988318130693362188
   PubMed Web of Science ®Google Scholar
• PecoraroRChronology and determination of tissue repair in diabetic lower extremity ulcersDiabetes1991401305131936593
   PubMed Web of Science ®Google Scholar
• PerssonUWillisMÖdegaardKThe cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost dataVal Health20003Suppl IS39S46
   Google Scholar
• PetrovaNEdmondsMEmerging drugs for diabetic foot ulcersExpert Opin Emerg Drugs2006117092417064227
   PubMedGoogle Scholar
• ReiberGEVileikyteLBoykoEJCausal pathways for incident lower-extremity ulcers in patients with diabetes from two settingsDiabetes Care1999221576210333919
   PubMed Web of Science ®Google Scholar
• ReiberGELedouxWRWilliamsRHermanWKinmothALEpidemiology of diabetic foot ulcers and complications: evidence for preventionThe evidence bas for diabetes care2002ChichesterWiley64165
   Google Scholar
• SibbaldRGTorranceGHuxMCost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcersOstomy Wound Manage200349768414652415
   PubMedGoogle Scholar
• SinghNArmstrongDGLipskyBAPreventing foot ulcers in patients with diabetesJAMA20032932172815644549
   PubMed Web of Science ®Google Scholar
• SmiellJMClinical safety of becaplermin (rhPDGF-BB) gelAm J Surg1998176Suppl 2A68S73S9777975
   PubMed Web of Science ®Google Scholar
• SmiellJMWiemanTJSteedDLEfficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studiesWound Rep Reg1999733546
   PubMed Web of Science ®Google Scholar
• SumpioBELeeTBlumePAVascular evaluation and arterial reconstruction of the diabetic footClin Podiatr Med Surg20032068970814636033
   PubMedGoogle Scholar
• SteedDLClinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcersJ Vasc Surg19952171817823364
   PubMed Web of Science ®Google Scholar
• SteedDLDebridementAm J Surg200418771S74S15147995
   PubMed Web of Science ®Google Scholar
• TentolourisNAl-SabbaghSWalkerMGMortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up studyDiabetes Care200427159860415220234
   PubMed Web of Science ®Google Scholar
• van HoutumRauwerdaJARuwaardDReduction in diabetes-related lower-extremity amputations in the Netherlands: 1991–2000Diabetes Care2004271042615111518
   PubMed Web of Science ®Google Scholar
• van HoutumWBarriers to the delivery of diabetic foot careLancet20053661678916291048
   PubMed Web of Science ®Google Scholar
• WatkinsPJThe diabetic footBMJ2003326977912727775
   PubMed Web of Science ®Google Scholar
• WiemanTJSmiellJMSuYEfficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (Becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind studyDiabetes Care19982182279589248
   PubMed Web of Science ®Google Scholar
• WiemanTJClinical efficacy of becaplermin (rhPDGF-BB) gelAm J Surg1998176Suppl 2A74S79S9777976
   PubMed Web of Science ®Google Scholar
• WildSRoglicGGreenAGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030Diabetes Care20042710475315111519
   PubMed Web of Science ®Google Scholar